β-Blocker Use for Patients With or at Risk for Coronary Artery Disease

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2013-02, Vol.309 (5), p.438-438
Main Authors: Costagliola, Dominique, Hernán, Miguel A
Format: Article
Language:English
Subjects:
Adrenergic beta-Antagonists - therapeutic use
Cardiovascular Diseases - mortality
Coronary Artery Disease - drug therapy
Coronary Artery Disease - mortality
Female
Humans
Male
Myocardial Infarction - drug therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a318t-617abca250093624c0ae29c6dd934ff52ad05078ce4950ba8378ea9dd1090e463
cites
container_end_page 438
container_issue 5
container_start_page 438
container_title JAMA : the journal of the American Medical Association
container_volume 309
creator Costagliola, Dominique
Hernán, Miguel A
description
doi_str_mv 10.1001/jama.2012.128862
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1285080593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1568244</ama_id><sourcerecordid>1285080593</sourcerecordid><originalsourceid>FETCH-LOGICAL-a318t-617abca250093624c0ae29c6dd934ff52ad05078ce4950ba8378ea9dd1090e463</originalsourceid><addsrcrecordid>eNo9kM1OwzAQhC0EoqVwRxxQjlxS1n-JfYQCBakSCFFxtNxkI9ImTbHTA6_Fg_BMOKR0LyvtzoxGHyHnFMYUgF4vbW3HDCgbU6ZUwg7IkEquYi61OiRDAK3iVCgxICfeLyEM5ekxGTDOlWQJDMn05zu-rZpshS6ae4yKxkUvti1x3frovWw_onCwbfRa-tXfc9K4Zm3dV3TjWgzrrvRoPZ6So8JWHs92e0TmD_dvk8d49jx9mtzMYsupauOEpnaRWSZDNZ4wkYFFprMkzzUXRSGZzUFCqjIUWsLCKp4qtDrPKWhAkfARuepzN6753KJvTV36DKvKrrHZehM4SFAgNQ9S6KWZa7x3WJiNK-tQ3VAwHT7T4TMdPtPjC5bLXfp2UWO-N_zzCoKLXtA593EyUUwI_gvieHL9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1285080593</pqid></control><display><type>article</type><title>β-Blocker Use for Patients With or at Risk for Coronary Artery Disease</title><source>JAMA</source><creator>Costagliola, Dominique ; Hernán, Miguel A</creator><creatorcontrib>Costagliola, Dominique ; Hernán, Miguel A</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2012.128862</identifier><identifier>PMID: 23385260</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Cardiovascular Diseases - mortality ; Coronary Artery Disease - drug therapy ; Coronary Artery Disease - mortality ; Female ; Humans ; Male ; Myocardial Infarction - drug therapy</subject><ispartof>JAMA : the journal of the American Medical Association, 2013-02, Vol.309 (5), p.438-438</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a318t-617abca250093624c0ae29c6dd934ff52ad05078ce4950ba8378ea9dd1090e463</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23385260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Costagliola, Dominique</creatorcontrib><creatorcontrib>Hernán, Miguel A</creatorcontrib><title>β-Blocker Use for Patients With or at Risk for Coronary Artery Disease</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Cardiovascular Diseases - mortality</subject><subject>Coronary Artery Disease - drug therapy</subject><subject>Coronary Artery Disease - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Myocardial Infarction - drug therapy</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNo9kM1OwzAQhC0EoqVwRxxQjlxS1n-JfYQCBakSCFFxtNxkI9ImTbHTA6_Fg_BMOKR0LyvtzoxGHyHnFMYUgF4vbW3HDCgbU6ZUwg7IkEquYi61OiRDAK3iVCgxICfeLyEM5ekxGTDOlWQJDMn05zu-rZpshS6ae4yKxkUvti1x3frovWw_onCwbfRa-tXfc9K4Zm3dV3TjWgzrrvRoPZ6So8JWHs92e0TmD_dvk8d49jx9mtzMYsupauOEpnaRWSZDNZ4wkYFFprMkzzUXRSGZzUFCqjIUWsLCKp4qtDrPKWhAkfARuepzN6753KJvTV36DKvKrrHZehM4SFAgNQ9S6KWZa7x3WJiNK-tQ3VAwHT7T4TMdPtPjC5bLXfp2UWO-N_zzCoKLXtA593EyUUwI_gvieHL9</recordid><startdate>20130206</startdate><enddate>20130206</enddate><creator>Costagliola, Dominique</creator><creator>Hernán, Miguel A</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130206</creationdate><title>β-Blocker Use for Patients With or at Risk for Coronary Artery Disease</title><author>Costagliola, Dominique ; Hernán, Miguel A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a318t-617abca250093624c0ae29c6dd934ff52ad05078ce4950ba8378ea9dd1090e463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Cardiovascular Diseases - mortality</topic><topic>Coronary Artery Disease - drug therapy</topic><topic>Coronary Artery Disease - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Myocardial Infarction - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Costagliola, Dominique</creatorcontrib><creatorcontrib>Hernán, Miguel A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Costagliola, Dominique</au><au>Hernán, Miguel A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-Blocker Use for Patients With or at Risk for Coronary Artery Disease</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2013-02-06</date><risdate>2013</risdate><volume>309</volume><issue>5</issue><spage>438</spage><epage>438</epage><pages>438-438</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><cop>United States</cop><pub>American Medical Association</pub><pmid>23385260</pmid><doi>10.1001/jama.2012.128862</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0098-7484
ispartof JAMA : the journal of the American Medical Association, 2013-02, Vol.309 (5), p.438-438
issn 0098-7484
1538-3598
language eng
recordid cdi_proquest_miscellaneous_1285080593
source JAMA
subjects Adrenergic beta-Antagonists - therapeutic use
Cardiovascular Diseases - mortality
Coronary Artery Disease - drug therapy
Coronary Artery Disease - mortality
Female
Humans
Male
Myocardial Infarction - drug therapy
title β-Blocker Use for Patients With or at Risk for Coronary Artery Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-Blocker%20Use%20for%20Patients%20With%20or%20at%20Risk%20for%20Coronary%20Artery%20Disease&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Costagliola,%20Dominique&rft.date=2013-02-06&rft.volume=309&rft.issue=5&rft.spage=438&rft.epage=438&rft.pages=438-438&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2012.128862&rft_dat=%3Cproquest_cross%3E1285080593%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a318t-617abca250093624c0ae29c6dd934ff52ad05078ce4950ba8378ea9dd1090e463%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1285080593&rft_id=info:pmid/23385260&rfr_iscdi=true